von der Grun J, Ahmadsei M, Breyer I, Britschgi C, Eberli D, Hermanns T
Neoplasia. 2024; 46:100946.
PMID: 39491410
PMC: 10630114.
DOI: 10.1016/j.neo.2023.100946.
Mittal A, Moore S, Navani V, Jiang D, Stewart D, Liu G
Curr Oncol. 2024; 31(7):3738-3751.
PMID: 39057147
PMC: 11276279.
DOI: 10.3390/curroncol31070275.
Smith K, Mead-Harvey C, Mazza G, Shinn E, Frank E, Melisko M
Cancer Med. 2024; 13(5):e7090.
PMID: 38466037
PMC: 10926883.
DOI: 10.1002/cam4.7090.
Agostinelli V, Ballatore Z, Ricci G, Lucarelli A, Burattini M, Mariotti L
Explor Target Antitumor Ther. 2023; 4(5):1095-1103.
PMID: 38023994
PMC: 10651351.
DOI: 10.37349/etat.2023.00183.
Ejem D, Wechsler S, Gallups S, Khalidi S, Coffee-Dunning J, Montgomery A
JCO Oncol Pract. 2023; 19(11):1020-1030.
PMID: 37733975
PMC: 10667016.
DOI: 10.1200/OP.23.00117.
Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials.
Lichtenstein M, Levit L, Schenkel C, Kirkwood K, Fashoyin-Aje L, Bruinooge S
Oncologist. 2023; 29(4):356-363.
PMID: 37676048
PMC: 10994398.
DOI: 10.1093/oncolo/oyad237.
External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations.
Silva P, Janjan N, Ramos K, Udeani G, Zhong L, Ory M
Front Med (Lausanne). 2023; 10:1198088.
PMID: 37484840
PMC: 10359981.
DOI: 10.3389/fmed.2023.1198088.
Commentary: Clinical research nurse utilisation and role in the conduct of decentralised clinical trials: a literature review.
Thomas Jones C
J Res Nurs. 2023; 28(3):227-229.
PMID: 37332315
PMC: 10272695.
DOI: 10.1177/17449871231163851.
Crisis of the Clinical Trials Staff Attrition After the COVID-19 Pandemic.
Sun G, Dizon D, Szczepanek C, Petrylak D, Sparks D, Tangen C
JCO Oncol Pract. 2023; 19(8):533-535.
PMID: 37285550
PMC: 10424897.
DOI: 10.1200/OP.23.00152.
Factors affecting the recruitment of Hispanic/Latinx American older adults in clinical trials in the United States: A scoping review.
Rodriguez D, Hewage S, Periyakoil V
J Am Geriatr Soc. 2023; 71(6):1974-1991.
PMID: 37013348
PMC: 10258132.
DOI: 10.1111/jgs.18264.
Timelines to initiate a phase III trial across the globe: a sub-analysis of the APHINITY trial.
Franzoi M, Procter M, Twelves C, Ponde N, Eiger D, Emond O
Ecancermedicalscience. 2022; 16:1379.
PMID: 35702414
PMC: 9116999.
DOI: 10.3332/ecancer.2022.1379.
COVID-19 Pandemic and Cancer Clinical Trial Pandemonium: Finding the Silver Lining.
Desai A, Subbiah V
J Immunother Precis Oncol. 2022; 4(2):64-66.
PMID: 35663538
PMC: 9153262.
DOI: 10.36401/JIPO-20-X7.
Development and evaluation of a clinical research nursing module for undergraduate nursing schools: expanding Clinical Research Nurses' outreach.
Capili B, Baker L, Thangthaeng N, Legor K, Larkin M, Jones C
J Res Nurs. 2022; 27(1-2):68-77.
PMID: 35392189
PMC: 8980585.
DOI: 10.1177/17449871211070972.
Lessons for Oncology From the COVID-19 Pandemic: Operationalizing and Scaling Virtual Cancer Care in Health Systems.
Roberts T, Lennes I
Cancer J. 2022; 28(2):125-133.
PMID: 35333498
PMC: 9158540.
DOI: 10.1097/PPO.0000000000000579.
Test/Retest Reliability and Validity of Remote vs. In-Person Anthropometric and Physical Performance Assessments in Cancer Survivors and Supportive Partners.
Hoenemeyer T, Cole W, Oster R, Pekmezi D, Pye A, Demark-Wahnefried W
Cancers (Basel). 2022; 14(4).
PMID: 35205823
PMC: 8869803.
DOI: 10.3390/cancers14041075.
The cost of cancer care: how far would you go for a trial?.
Fitzpatrick O, Murphy C, Duignan E, Egan K, Hennessy B, Grogan L
Ir J Med Sci. 2022; 191(6):2487-2491.
PMID: 35038110
PMC: 8761872.
DOI: 10.1007/s11845-021-02915-6.
The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.
Sessa C, Cortes J, Conte P, Cardoso F, Choueiri T, Dummer R
ESMO Open. 2021; 7(1):100339.
PMID: 34953404
PMC: 8608656.
DOI: 10.1016/j.esmoop.2021.100339.
The Impact of COVID-19 on National Clinical Trials Network Breast Cancer Trials.
Ndumele A, Park K
Curr Breast Cancer Rep. 2021; 13(3):103-109.
PMID: 33995839
PMC: 8112880.
DOI: 10.1007/s12609-021-00417-z.
Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420).
Lara Gongora A, Werutsky G, Jardim D, Nogueira-Rodrigues A, Barrios C, Mathias C
JCO Glob Oncol. 2021; 7:649-658.
PMID: 33956499
PMC: 8162498.
DOI: 10.1200/GO.20.00663.
Resilience and ongoing quality care for cancer clinical trials during COVID-19: Experience from a tertiary hospital in Australia.
Ives A, Pusztai T, Keller J, Ahern E, Chan B, Gasper H
Asia Pac J Clin Oncol. 2021; 18(2):e141-e147.
PMID: 33819387
PMC: 8251164.
DOI: 10.1111/ajco.13570.
